Literature DB >> 24865566

Post-contrast myocardial T(1) and ECV disagree in a longitudinal canine study.

Matthias Koopmann1, KyungPyo Hong, Eugene G Kholmovski, Eric C Huang, Nan Hu, Jian Ying, Richard Levenson, Sathya Vijayakumar, Derek J Dosdall, Ravi Ranjan, Daniel Kim.   

Abstract

Both post-contrast myocardial T1 and extracellular volume (ECV) measurements have been associated with diffuse interstitial fibrosis. The cardiovascular magnetic resonance (CMR) field is migrating towards ECV, because it is largely insensitive to confounders that affect post-contrast myocardial T1 . Despite the theoretical advantages of myocardial ECV over post-contrast myocardial T1 , systematic experimental studies comparing the two measurements are largely lacking. We sought to measure the temporal changes in post-contrast myocardial T1 and ECV in an established canine model with chronic atrial fibrillation. Seventeen mongrel dogs, implanted with a pacemaker to induce chronic atrial fibrillation via rapid atrial pacing, were scanned multiple times for a total of 46 CMR scans at 3T. These dogs with different disease durations (0-22 months) were part of a separate longitudinal study aimed at studying the relationship between AF and pathophysiology. In each animal, we measured native and post-contrast T1 values and hematocrit. Temporal changes in post-contrast myocardial T1 and ECV, as well as other CMR parameters, were modeled with linear mixed effect models to account for repeated measurements over disease duration. In 17 animals, post-contrast myocardial T1 decreased significantly from 872 to 698 ms (p < 0.001), which corresponds to a 24.9% relative reduction. In contrast, ECV increased from 21.0 to 22.0% (p = 0.38), which corresponds to only a 4.5% relative increase. To partially investigate this discrepancy, we quantified collagen volume fraction (CVF) in post-mortem heart tissues of six canines sacrificed at different disease durations (0-22 months). CVF quantified by histology increased from 0.9 to 1.9% (p = 0.56), which agrees better with ECV than with post-contrast myocardial T1 . This study shows that post-contrast myocardial T1 and ECV may disagree in a longitudinal canine study. A more comprehensive study, including histologic, cardiac, and renal functional analyses, is warranted to test rigorously which CMR parameter (ECV or post-contrast myocardial T1 ) agrees better with CVF.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MRI; atrial fibrillation; collagen volume fraction; diffuse myocardial fibrosis; extracellular volume fraction; heart failure; post-contrast myocardial T1

Mesh:

Substances:

Year:  2014        PMID: 24865566      PMCID: PMC4227501          DOI: 10.1002/nbm.3135

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  22 in total

1.  Cine MR angiography of the heart with segmented true fast imaging with steady-state precession.

Authors:  J C Carr; O Simonetti; J Bundy; D Li; S Pereles; J P Finn
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

2.  Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.

Authors:  Liang-Han Ling; Peter M Kistler; Andris H Ellims; Leah M Iles; Geraldine Lee; Gerard L Hughes; Jonathan M Kalman; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2012-11-07       Impact factor: 24.094

3.  Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Authors:  Andrew S Flett; Martin P Hayward; Michael T Ashworth; Michael S Hansen; Andrew M Taylor; Perry M Elliott; Christopher McGregor; James C Moon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

4.  Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease.

Authors:  Craig S Broberg; Sumeet S Chugh; Catherine Conklin; David J Sahn; Michael Jerosch-Herold
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-20       Impact factor: 7.792

5.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Authors:  Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

6.  Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission.

Authors:  Timothy C Wong; Kayla M Piehler; Ian A Kang; Ajay Kadakkal; Peter Kellman; David S Schwartzman; Suresh R Mulukutla; Marc A Simon; Sanjeev G Shroff; Lewis H Kuller; Erik B Schelbert
Journal:  Eur Heart J       Date:  2013-06-11       Impact factor: 29.983

7.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

8.  Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.

Authors:  Marianna Fontana; Steve K White; Sanjay M Banypersad; Daniel M Sado; Viviana Maestrini; Andrew S Flett; Stefan K Piechnik; Stefan Neubauer; Neil Roberts; James C Moon
Journal:  J Cardiovasc Magn Reson       Date:  2012-12-28       Impact factor: 5.364

9.  Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus.

Authors:  Erik B Schelbert; Stephen M Testa; Christopher G Meier; William J Ceyrolles; Joshua E Levenson; Alexander J Blair; Peter Kellman; Bobby L Jones; Daniel R Ludwig; David Schwartzman; Sanjeev G Shroff; Timothy C Wong
Journal:  J Cardiovasc Magn Reson       Date:  2011-03-04       Impact factor: 5.364

10.  Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.

Authors:  Christopher A Miller; Josephine H Naish; Paul Bishop; Glyn Coutts; David Clark; Sha Zhao; Simon G Ray; Nizar Yonan; Simon G Williams; Andrew S Flett; James C Moon; Andreas Greiser; Geoffrey J M Parker; Matthias Schmitt
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-03       Impact factor: 7.792

View more
  6 in total

Review 1.  Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease.

Authors:  Craig S Broberg; Luke J Burchill
Journal:  Int J Cardiol       Date:  2015-04-10       Impact factor: 4.164

Review 2.  MRI use for atrial tissue characterization in arrhythmias and for EP procedure guidance.

Authors:  Ehud J Schmidt; Henry R Halperin
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-07       Impact factor: 2.357

3.  MOLLI and AIR T1 mapping pulse sequences yield different myocardial T1 and ECV measurements.

Authors:  KyungPyo Hong; Daniel Kim
Journal:  NMR Biomed       Date:  2014-11       Impact factor: 4.044

4.  Dose correction for post-contrast T1 mapping of the heart: the MESA study.

Authors:  Neville D Gai; Veit Sandfort; Songtao Liu; João A C Lima; David A Bluemke
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-11       Impact factor: 2.357

5.  Left ventricular extracellular volume expansion does not predict recurrence of atrial fibrillation following catheter ablation.

Authors:  Suvai Gunasekaran; Daniel C Lee; Bradley P Knight; Jeremy D Collins; Lexiaozi Fan; Amar Trivedi; Ann B Ragin; James C Carr; Rod S Passman; Daniel Kim
Journal:  Pacing Clin Electrophysiol       Date:  2020-01-09       Impact factor: 1.976

6.  Left Ventricular Extracellular Volume Expansion Is Not Associated with Atrial Fibrillation or Atrial Fibrillation-mediated Left Ventricular Systolic Dysfunction.

Authors:  Suvai Gunasekaran; Daniel C Lee; Bradley P Knight; Lexiaozi Fan; Jeremy D Collins; Kelvin Chow; James C Carr; Rod Passman; Daniel Kim
Journal:  Radiol Cardiothorac Imaging       Date:  2020-04-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.